On March 15, 2017, OmniComm Systems, Inc. announced that its board of directors approved a reorganization of the company's executive management team designed to provide for the orderly succession of management responsibilities. In connection with the reorganization, the board of directors established two new company executive management positions: ‘executive chairman' which position will function as both principal executive officer of the company and as executive chairman of the board of directors, and ‘executive vice chairman' which position will function as both an executive officer of the company and as executive vice chairman of the board of directors. Except as otherwise noted, the following changes in the organization of the company are effective June 1, 2017.

Cornelis F. Wit is transitioning his position in the company from and as the company's chief executive officer and director to and has been named by the company's board of directors as the company's executive chairman and executive chairman of the board of directors. Mr. Wit has been the company's chief executive officer since June of 2002, served as the company's interim chief executive officer from June to July 2000, and has been a member of the company's board of directors since November 1999. As executive chairman, Mr. Wit will continue to report directly to the board of directors.

Stephen E. Johnson, the company's current president and chief operating officer, has been named by the company's board of directors to succeed Mr. Wit as chief executive officer. Mr. Johnson will assume the role of CEO-designate immediately and will transition to the role of chief executive officer, and resign as chief operating officer, upon Mr. Wit's resignation as chief executive officer. Mr. Johnson will also continue to hold his position as the company's president.

Mr. Johnson has served as the company's president since June 1, 2010, as the company's chief operating officer since April 2008, and as the company's executive vice president, national sales from September 2006 to April 2008. As chief executive officer, Mr. Johnson will continue to report directly to Mr. Wit. Randall G. Smith is transitioning his position in the company, effective June 1, 2017, from and as the company's chief technology officer and chairman of the board of directors to and has been named by the company's board of directors as the company's executive vice chairman (executive officer of the company) and executive vice chairman of the board of directors.

Mr. Smith has served as the company's chief technology officer and chairman of the board of directors since May 1997, and as the company's president from May 1997 to August 2000. Effective June 1, 2017, Mr. Smith's services will be modified commensurate to his new position with the company. As executive vice chairman, Mr. Smith will continue to report directly to Mr. Wit.

John Fontenault, the company's current senior vice president of operations, has been named as the company's chief operating officer and will transition to the role of chief operating officer upon Mr. Johnson's resignation as chief operating officer on June 1, 2017. Mr. Fontenault will continue to report directly to Mr. Johnson. Mr. Fontenault has served as senior vice president of operations since October 2013.

Mr. Fontenault previously served as VP of Operations with ER Squared, providing strategic eClinical business process and technology consulting; prior to that Mr. Fontenault was Executive Director and Global Head of Clinical Data Management and Technology at Kendle International. Mr. Fontenault also spent 17 years as a Clinical Systems leader at both Bayer Healthcare and Purdue Pharma. Keith Howells, the company's current senior vice president of development, has been named as chief technology officer and will transition to the role of chief technology officer upon Mr. Smith's resignation as chief technology officer on June 1, 2017.

Mr. Howells will report directly to Mr. Johnson. Mr. Howells has served as head of product development, initially for TrialMaster and the eClinical Suite and subsequently for TrialOne as well, since January 2011. Prior to joining the company, Mr. Howells was Senior Vice President of Development for Medidata Solutions from 2005 to 2010.

Kuno van der Post, senior vice president of business development, has been promoted to chief commercial officer (CCO). Ken Light, executive vice president of professional services, has been promoted to executive vice president of corporate strategy. All of the management changes will be effective June 1, 2017.